XML 61 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Jul. 31, 2012
Jul. 31, 2011
Cash flows from operating activities:    
Net income $ 27,808 $ 21,876
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 18,657 17,951
Amortization of debt issuance costs 357 357
Share-based compensation 3,063 2,184
Provision for bad debts 113 140
Write-down for inventory obsolescence 533 626
Profit on sale of leased assets (721) (4,182)
Loss on sale of assets 231 238
Excess tax benefit from exercise of stock options (1,370) (808)
Changes in operating assets and liabilities:    
Accounts receivable and investment in sales-type leases and notes receivable (5,191) 3,961
Inventories (3,261) (3,948)
Accounts payable and accrued liabilities (2,658) (21,232)
Customer deposits and deferred revenue 561 825
Income taxes payable 3,300 3,666
Deferred income taxes 2,590 1,036
Prepaid income taxes (4,714) 3,812
Other (3,430) 10,190
Net cash provided by operating activities 35,868 36,692
Cash flows from investing activities:    
Proceeds from sale of leased assets 1,640 6,240
Proceeds from sale of assets   86
Payments for products leased and held for lease (11,227) (11,608)
Purchases of property and equipment (5,852) (2,683)
Purchases of intangible assets (4,333) (6,269)
Acquisition of business (5,500) (6,499)
Other (690) (701)
Net cash used in investing activities (25,962) (21,434)
Cash flows from financing activities:    
Proceeds from Revolver 11,000 16,500
Debt payments on Revolver (34,000) (15,000)
Proceeds from issuances of common stock, net 16,238 2,156
Excess tax benefit from exercise of stock options 1,370 808
Other (43) (41)
Net cash provided by (used in) financing activities (5,435) 4,423
Effect of exchange rate changes on cash and cash equivalents 1,370 522
Net increase in cash and cash equivalents 5,841 20,203
Cash and cash equivalents, beginning of period 22,189 9,988
Cash and cash equivalents, end of period $ 28,030 $ 30,191